Table 1.
Target Protein | Phosphosite | Effect of Phosphorylation | Relative Phosphorylation | Fold Change | ||
---|---|---|---|---|---|---|
PA | CAE | CAE/PA | p-Value | |||
Insulin signaling | ||||||
IGF1R | Y1165 | Induces activity | 0.23 ± 0.02 | 0.45 ± 0.04 | 1.99 ± 0.22 | 0.033 * |
INSR | Y1189 | Induces activity | 0.68 ± 0.05 | 1.96 ± 0.11 | 2.87 ± 0.21 | 0.009 ** |
IRS-1 | S318 | Inhibits molecular association | 0.06 ± 0.01 | 0.26 ± 0.03 | 4.28 ± 0.48 | 0.020 * |
SHC-1 | Y427 | Induces activity | 0.18 ± 0.02 | 0.32 ± 0.05 | 1.77 ± 0.35 | 0.117 |
SHIP-1 | Y1020 | Induces activity | 0.13 ± 0.01 | 0.30 ± 0.05 | 2.21 ± 0.39 | 0.060 |
SHP-2 | T542 | Induces molecular association | 0.34 ± 0.03 | 0.56 ± 0.04 | 1.65 ± 0.21 | 0.081 |
PI3K-AKT-PKB signaling | ||||||
AKT | S473 | Induces activity | 0.57 ± 0.04 | 1.54 ± 0.09 | 2.71 ± 0.21 | 0.011 * |
BAD | S112 | Inhibits molecular association | 0.29 ± 0.02 | 1.08 ± 0.11 | 3.65 ± 0.32 | 0.008 ** |
GSK3α | S21 | Inhibits activity | 0.46 ± 0.03 | 1.31 ± 0.08 | 2.85 ± 0.20 | 0.008 ** |
GSK3β | S9 | Inhibits activity | 0.67 ± 0.02 | 1.44 ± 0.12 | 2.15 ± 0.17 | 0.012 * |
PDK1 | S241 | Induces activity | 0.63 ± 0.02 | 1.24 ± 0.08 | 1.97 ± 0.14 | 0.013 * |
PTEN | S370 | Inhibits activity | 0.40 ± 0.05 | 1.85 ± 0.08 | 4.65 ± 0.39 | 0.008 ** |
mTOR/S6K signaling | ||||||
4E-BP1 | T36 | Inhibits activity | 0.95 ± 0.03 | 1.77 ± 0.39 | 1.86 ± 0.35 | 0.075 |
EIF4E | S209 | Inhibits molecular interaction | 0.10 ± 0.01 | 0.22 ± 0.01 | 2.12 ± 0.24 | 0.038 * |
mTOR | T2448 | Induces activity | 0.73 ± 0.07 | 1.64 ± 0.17 | 2.23 ± 0.29 | 0.038 * |
p70S6K | T421/S424 | Induces activity | 0.61 ± 0.02 | 0.94 ± 0.09 | 1.54 ± 0.17 | 0.055 |
PRAS40 | T246 | Inhibits activity | 0.63 ± 0.04 | 1.38 ± 0.16 | 2.19 ± 0.26 | 0.026 * |
rpS6 | S235/236 | Induces activity | 0.87 ± 0.08 | 2.21 ± 0.06 | 2.55 ± 0.19 | 0.014 * |
FoxO signaling | ||||||
FOXO3 | S413 | Induces activity | 0.02 ± 0.00 | 0.04 ± 0.01 | 2.12 ± 0.39 | 0.074 |
p27 | T198 | Inhibits molecular interaction | 0.38 ± 0.05 | 1.00 ± 0.10 | 2.61 ± 0.38 | 0.038 * |
AMPK signaling | ||||||
AMPKα | T172 | Induces activity | 0.65 ± 0.03 | 1.55 ± 0.09 | 2.38 ± 0.16 | 0.009 ** |
LKB1 | S428 | Induces activity | 0.44 ± 0.05 | 1.00 ± 0.05 | 2.24 ± 0.25 | 0.036 * |
p53 | S15 | Induces activity | 0.60 ± 0.03 | 1.70 ± 0.13 | 2.85 ± 0.20 | 0.007 * |
MAPK signaling | ||||||
ERK1/2 | T202/Y204 Y185/187 |
Induces activity | 0.50 ± 0.02 | 1.51 ± 0.10 | 2.99 ± 0.19 | 0.006 ** |
Raf-1 | S301 | Inhibits activity | 0.51 ± 0.06 | 1.48 ± 0.11 | 2.88 ± 0.33 | 0.022 * |
RSK1 | S380 | Induces protein degradation | 0.49 ± 0.03 | 1.19 ± 0.05 | 2.45 ± 0.15 | 0.008 ** |
RSK2 | S386 | Induces activity | 0.71 ± 0.03 | 1.38 ± 0.05 | 1.96 ± 0.11 | 0.009 ** |
Results are reported as mean ± SD (n = 3). p-values followed by *, **, indicate a statistically significance difference between PA and CAE groups when subjected to the t-test (p < 0.05, p < 0.01, p < 0.001, respectively).